| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5913535 | Blood Cells, Molecules, and Diseases | 2014 | 5 Pages |
Abstract
This post hoc analysis suggests improvement in BMB scores through 5Â years that was sustained through 7Â years, despite dose reduction from 15Â months. Prospective studies in a large cohort are needed to validate these findings.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
Deborah Elstein, Andrew H. Haims, David Zahrieh, Gabriel M. Cohn, Ari Zimran,